Oncology

Over the next 3 years, IDEXX Cancer Dx will expand to include most canine cancer cases

Integrative therapies can enhance a patient’s survival and quality of life

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights.

Canalevia-CA1 is currently the only treatment on the market for treating CID in canine patients.

Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Calviri recently announced the initiation of new vaccine trial that targets early-stage hemangiosarcoma tumors in canines

Rachel Allbaugh, DVM, MS, DACVO, explains her squamous cell carcinoma diagnosis procedure, beyond just the clinical signs

The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the most common feline diseases

CureLab Veterinary Inc is conducting a Regulation D fundraising offering for its gene therapy, ElenaVet

New research has uncovered gene responsible for graying speeds in horses, and a predisposition to melanoma

A BluePearl hospital in Malvern, Pennsylvania, is the first veterinary hospital to utilize this technology

FidoCure used AI technology to aid in the development of the new oncology drug

What can general practitioners do in a primary care setting?

A new study showed that this cell-sizing method is useful for characterizing feline lymphoma and predicting patient survival time

Recognizing PNS can help veterinarians identify neoplasia earlier and improve the quality of life in patients with cancer

Craig A Clifford DVM, MS, DACVIM (Oncology), gives an inside look into his upcoming Fetch Kansas City lecture on canine lymphoma

ELIAS Animal health will combine its adoptive T cell therapy with a new adjuvant in an upcoming study

Researchers within the United States are investigating risk factors for osteosarcoma in canine and human patients

The therapy demonstrated an 88% resolution rate in one study

The EpiSwitch Specific Canine Blood test can detect up to 6 types of cancer in canines in a single array format

Calviri has gathered results from its 5-year study, revealing positive outcomes for cancer prevention

Although chemotherapy is well tolerated in dogs and cats, with most pets feeling well through treatment, adverse effects can occur.

A study conducted by researchers Texas A&M showed proton pump inhibitors could increase the effectiveness of chemotherapy

Rachel Venable, DVM, MS, DACVIM (Oncology) presented oncology updates to general practitioners at Fetch Nashville

Jaguar Health established an Investigation New Animal Drug file for its product Canalevia-CA1

Nu. Q Vet Cancer Test is now available through Antech

Morris Animal Foundation and Golden Retriever Foundation fund a study that examines dogs at high risk for developing diffuse large B-cell lymphoma

Updates on the small animal veterinarian raising awareness of the illegal wildlife trade; the former veterinarian now specialist medical oncologist at the forefront of melanoma research in Australia; and a global win for Aussie animal biotechnology company VetChip.

VolitionRx Limited entered an supply agreement with Fujiflim Vet Systems Co. Ltd, to launch Nu.Q Vet Cancer Test in Japan